Missed diagnostic testing has negative impact on lung cancer treatment
the ONA take:
A team of researchers from the Baptist Cancer Center and the University of Memphis, Tennessee, sought to identify the impact of factors associated with care delivery on prognosis for patients with lung cancer.
Their results show that only 1 in 10 patients with lung cancer underwent the recommended combination of diagnostic tests before surgery. In addition, patients waited 1.5 to 6 months to undergo surgery after suspicions of lung cancer are made via radiography.
Recommendations suggest three staging tests before surgery in patients for suspected lung cancer: computed tomography (CT), positron emission tomography (PET), and a biopsy.
According to the study results, 88% of patients did not undergo biopsy, no imaging test was obtained in 22% of patients, and no diagnostic procedure was done before surgery in 27% of patients.
The researchers conclude that delays in final treatment and missed diagnostic tests can hinder outcomes for patients with lung cancer.
Their results highlight the importance of engaging patients in their care from early on to determine the best tests that will lead to an optimal treatment course for that patient.
A team sought to identify the impact of factors associated with care delivery on prognosis for patients with lung cancer.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Risk Factors for Brain Metastases in HER2+ Breast Cancer Identified in Analysis
- Intermediate Oncotype DX Scores Prognostic of OS in Early-stage Breast Cancer
- Colorectal Cancer and Dietary Fiber: Source Is More Important Than Amount
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
- Exercise May Mitigate Cardiotoxicity Associated With Doxorubicin Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|